These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 11916076

  • 1. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
    Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, Giles AR, Yoshioka A.
    Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors.
    Kasuda S, Tanaka I, Shima M, Matsumoto T, Sakurai Y, Nishiya K, Giles AR, Yoshioka A.
    Haemophilia; 2004 Jul; 10(4):341-6. PubMed ID: 15230947
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
    Gilmore R, Harmon S, Gannon C, Byrne M, O'Donnell JS, Jenkins PV.
    Haemophilia; 2010 Jul 01; 16(4):671-4. PubMed ID: 20148980
    [Abstract] [Full Text] [Related]

  • 7. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.
    Rodgers SE, Duncan EM, Barbulescu DM, Quinn DM, Lloyd JV.
    Br J Haematol; 2007 Jan 01; 136(1):138-45. PubMed ID: 17222201
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Normalization of factor VIII levels in a patient with mild haemophilia A during a 35-year period.
    Mainwaring CJ, Evans J, Chana J, Lewis H.
    Haemophilia; 2006 Nov 01; 12(6):668-71. PubMed ID: 17083519
    [Abstract] [Full Text] [Related]

  • 10. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
    Mischke R.
    Dtsch Tierarztl Wochenschr; 1993 Jun 01; 100(6):219-22. PubMed ID: 8339706
    [Abstract] [Full Text] [Related]

  • 11. A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.
    Matsumoto T, Nogami K, Ogiwara K, Shima M.
    Int J Hematol; 2009 Dec 01; 90(5):576-582. PubMed ID: 19937483
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A.
    Gu JM, Ramsey P, Evans V, Tang L, Apeler H, Leong L, Murphy JE, Laux V, Myles T.
    Haemophilia; 2014 Jul 01; 20(4):593-600. PubMed ID: 24471985
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.
    Matsumoto T, Shima M, Takeyama M, Yoshida K, Tanaka I, Sakurai Y, Giles AR, Yoshioka A.
    J Thromb Haemost; 2006 Feb 01; 4(2):377-84. PubMed ID: 16420569
    [Abstract] [Full Text] [Related]

  • 16. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent.
    Mazurier C, Parquet-Gernez A, Goudemand M.
    Thromb Haemost; 1990 Oct 22; 64(2):251-5. PubMed ID: 2125374
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.
    Baig MA, Swamy KB.
    Indian J Pathol Microbiol; 2021 Oct 22; 64(1):123-127. PubMed ID: 33433421
    [Abstract] [Full Text] [Related]

  • 20. Performance of recalibrated ReFacto laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto (B-domain deleted recombinant factor VIII).
    Santoro C, Iorio A, Ferrante F, Pallotta A, Pignoloni P, Biondo F, Agnelli G, Mazzucconi MG.
    Haemophilia; 2009 May 22; 15(3):779-87. PubMed ID: 19298379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.